Daunorubicin, liposomal

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Half-life
This section has been translated automatically.

11–27 h

Indication
This section has been translated automatically.

Pregnancy/nursing period
This section has been translated automatically.

Contraindicated.

Dosage and method of use
This section has been translated automatically.

40 mg/m2 KO i.v. every 2 weeks.

Undesirable effects
This section has been translated automatically.

Altogether few UAWs! Rarely alopecia, gastrointestinal disorders, disorders of hematopoiesis, fever, urticaria, angioedema, palmoplantar erxthrodysesthesia.

Contraindication
This section has been translated automatically.

Hypersensitivity to anthracyclines or anthracenediones.

Preparations
This section has been translated automatically.

Daunoblastine, DaunoXome

Note(s)
This section has been translated automatically.

Remember! During the therapy and up to 6 months after contraception!

Authors

Last updated on: 29.10.2020